Article
Targeted Transcriptome and KRAS Mutation Analysis Improve the Diagnostic Performance of EUS-FNA Biopsies in Pancreatic Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Nov 2021
Lundy Joanne, Gao Hugh, Berry William, Masoumi-Moghoddam Samar, Jenkins Brendan J, Croagh Daniel
Abstract excerpt
PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosis, and current diagnostic tests have suboptimal sensitivity. Incorporating standard cytology with targeted transcriptomic and mutation analysis may improve upon the accuracy of diagnostic biopsies, thus reducing the burden of repeat procedures and delays to treatment initiation. EXPERIMENTAL DESIGN: We reviewed the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
